Medicare Enrolled
Dr. Michael Sheran, MD
Internal Medicine · Kingston, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sheran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sheran
Dr. Michael Sheran is an internal medicine specialist in Kingston, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sheran performed 3,422 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sheran received a total of $33,114 from 75 pharmaceutical and/or device companies across 966 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sheran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in NY
$33,114 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,422
Medicare services
Top 10% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
550 | $44 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
436 | $48 | $201 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
291 | $41 | $136 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
108 | $29 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
102 | $12 | $27 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
92 | $69 | $80 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
62 | $277 | $350 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
61 | $29 | $30 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
57 | $3 | $4 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
34 | $49 | $65 |
| Annual alcohol misuse screening, 5 to 15 minutes | 34 | $20 | $30 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
32 | $10 | $15 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
28 | $34 | $48 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $38 | $35 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
22 | $156 | $194 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
20 | $13 | $20 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
19 | $22 | $50 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $41 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$33,114
Total received (2018-2024)
Avg $4,731/year across 7 years
Top 3% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
966
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,481
2023
$2,547
2022
$2,375
2021
$1,709
2020
$1,174
2019
$12,687
2018
$10,143
Payments by company (2024)
ABBVIE INC.
$507
ViiV Healthcare Company
$407
AstraZeneca Pharmaceuticals LP
$248
Gilead Sciences, Inc.
$210
Lilly USA, LLC
$149
PFIZER INC.
$148
Bayer Healthcare Pharmaceuticals Inc.
$146
Merck Sharp & Dohme LLC
$112
Amgen Inc.
$110
SANOFI-AVENTIS U.S. LLC
$70
Otsuka America Pharmaceutical, Inc.
$63
Dexcom, Inc.
$57
Novartis Pharmaceuticals Corporation
$42
Endo USA, Inc.
$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Kyowa Kirin, Inc.
$26
Inspire Medical Systems, Inc.
$23
Abbott Laboratories
$22
Melinta Therapeutics, LLC
$17
GlaxoSmithKline, LLC.
$16
Novo Nordisk Inc
$16
IBSA Pharma Inc.
$16
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$18,822
ViiV Healthcare Company
$1,920
AstraZeneca Pharmaceuticals LP
$1,179
ABBVIE INC.
$938
Lilly USA, LLC
$882
GlaxoSmithKline, LLC.
$833
PFIZER INC.
$780
Novartis Pharmaceuticals Corporation
$724
Novo Nordisk Inc
$588
AbbVie Inc.
$582
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$564
Amgen Inc.
$512
Janssen Pharmaceuticals, Inc
$512
Janssen Biotech, Inc.
$352
Merck Sharp & Dohme LLC
$314
Merck Sharp & Dohme Corporation
$313
Bayer Healthcare Pharmaceuticals Inc.
$248
AbbVie, Inc.
$160
Astellas Pharma US Inc
$156
Allergan Inc.
$156
Amarin Pharma Inc.
$143
E.R. Squibb & Sons, L.L.C.
$135
Endo Pharmaceuticals Inc.
$134
Allergan, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
Harmony Biosciences LLC
$113
Regeneron Healthcare Solutions, Inc.
$108
Sunovion Pharmaceuticals Inc.
$97
Otsuka America Pharmaceutical, Inc.
$97
Celgene Corporation
$86
SANOFI-AVENTIS U.S. LLC
$85
TETRAPHASE PHARMACEUTICALS, INC.
$74
Dexcom, Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$69
Kyowa Kirin, Inc.
$64
Fresenius Kabi USA, LLC
$59
Grifols USA, LLC
$54
Theratechnologies Inc.
$43
IBSA Pharma Inc.
$41
Endo USA, Inc.
$38
Seqirus USA Inc
$37
Sanofi Pasteur Inc.
$36
Melinta Therapeutics, LLC
$36
Abbott Laboratories
$34
Eisai Inc.
$32
Melinta Therapeutics, Inc.
$28
Sumitomo Pharma America, Inc.
$28
Antares Pharma, Inc.
$26
Aurinia Pharma U.S., Inc.
$26
GENZYME CORPORATION
$25
Almatica Pharma LLC
$24
Inspire Medical Systems, Inc.
$23
Sandoz Inc.
$23
Indivior Inc.
$22
Neurocrine Biosciences, Inc.
$21
Medtronic Vascular, Inc.
$19
Sobi, Inc
$19
Flexion Therapeutics, Inc.
$18
DEXCOM, INC.
$18
Vyera Pharmaceuticals, LLC
$17
Exact Sciences Corporation
$16
SOBI, INC
$16
Edwards Lifesciences Corporation
$16
RECORDATI_RARE_DISEASES_INC.
$15
Teva Pharmaceuticals USA, Inc.
$15
VBI Vaccines (Delaware) Inc.
$14
Medtronic, Inc.
$14
INSYS Therapeutics Inc
$13
Avanir Pharmaceuticals, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Hologic, LLC
$12
ARBOR PHARMACEUTICALS, INC.
$12
Collegium Pharmaceutical, Inc.
$11
Exsomed Holding Company LLC
$9
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · AIRSUPRA · AJOVY · AMJEVITA · ANORO · APRETUDE · AREXVY · AVYCAZ · Age Based Codes · Aimovig · BASAGLAR · BELSOMRA · BENLYSTA · BEXSERO · BREO · BREZTRI · BYSTOLIC · Baxdela · Biktarvy · CABENUVA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CUVITRU · ClosureRFS · Cologuard Collection Kit · Crysvita · DALVANCE · DEXCOM G6 TRANSMITTER · DOVATO · Daraprim Tablet 25mg · Dayvigo · Dexcom G6 Transmitter · EGRIFTA · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVUSHELD · Edwards SAPIEN 3 Transcatheter Heart Valve · Enbrel · FARXIGA · FASENRA · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre · GARDASIL · GEMTESA · GRALISE · Gamunex-C · HYQVIA · HYRIMOZ · Horizant · Humira · INFLECTRA · INGREZZA · INSPIRE · INTERSTIM · INVOKANA · ISENTRESS · JANUVIA · JARDIANCE · JULUCA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · Kerendia · Kimyrsa · Kineret · LEQVIO · LICART · LINZESS · LUPKYNIS · LYRICA · MENACTRA · MOUNJARO · MYRBETRIQ · Myrbetriq · NUCALA · NUEDEXTA · NURTEC ODT · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orbactiv · Otezla · Ozempic · PANZYGA · PERSERIS · PIFELTRO · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 20 · PREZCOBIX · PreHevbrio · Prolastin-C · Prolia · QULIPTA · RENFLEXIS · REXULTI · RINVOQ · RUKOBIA · RYBELSUS · Rinvoq · Rybelsus · SAPHNELO · SHINGRIX · SIGNIFOR LAR · SIMPONI · SIMPONI ARIA · SPIRIVA RESPIMAT · STELARA · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · SYNDROS · SYNTHROID · Seglentis · Symtuza · Synthroid · TALTZ · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRIUMEQ · TRULANCE · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · UBRELVY · VRAYLAR · Vascepa · Veozah · Victoza · WAKIX · XARELTO · XERAVA · XIAFLEX · XIFAXAN · XTAMPZA · XYOSTED · Xerava · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
169
County median income
$81,804
Nearest hospital to ZIP centroid (approximate)
HEALTHALLIANCE HOSPITAL MARYS AVENUE CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sheran is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sheran experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sheran performed 1,440 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sheran receive payments from pharmaceutical companies?
Yes. Dr. Sheran received a total of $33,114 from 75 companies across 966 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheran's costs compare to other internal medicine physicians in Kingston?
Dr. Sheran's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Kingston
Browse internal medicine physicians in Kingston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology